Company
Reset Pharma
Also known as Reset Pharmaceuticals, Inc
- Legal name
- Reset Pharmaceuticals, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Reset Pharma is a privately-held biotechnology company focused on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, including cancer. The company’s lead program focuses on psilocybin with psychotherapy for patients with cancer related demoralization, anxiety and depression. Reset Pharma has established a highly experienced biotech development team and has a Scientific Advisory Board of leading experts in psychiatry, oncology and psychedelics.
Funding snapshot
- Total raised
- $11.1MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $11.1M2021-11-26
Funding rounds
- Round, 2021
- $11.1M2021-11-26, SEC form D sold, 26 investors
Loading relationship preview